Hypertensive disorders of pregnancy in Hunan Province, China, 2012-2022.

IF 3.1 3区 医学 Q1 MEDICINE, GENERAL & INTERNAL Frontiers in Medicine Pub Date : 2024-12-20 eCollection Date: 2024-01-01 DOI:10.3389/fmed.2024.1415696
Xu Zhou, Yinglan Wu, Xiaoying Chen, Yurong Jiang
{"title":"Hypertensive disorders of pregnancy in Hunan Province, China, 2012-2022.","authors":"Xu Zhou, Yinglan Wu, Xiaoying Chen, Yurong Jiang","doi":"10.3389/fmed.2024.1415696","DOIUrl":null,"url":null,"abstract":"<p><strong>Objective: </strong>To explore the relationship between hypertensive disorders of pregnancy (HDP) and adverse pregnancy outcomes and explore the risk factors for HDP.</p><p><strong>Methods: </strong>Data were obtained from the Maternal Near-Miss Surveillance System in Hunan Province, China, 2012-2022. Chi-square trend tests (<i>χ<sup>2</sup></i> <sub>trend</sub>) were used to determine trends in prevalence by year. Unadjusted odds ratios (uORs) were used to examine the association between HDP and adverse pregnancy outcomes. Multivariate logistic regression analysis (method: Forward, Wald, <i>α</i> = 0.05) and adjusted odds ratios (aORs) were used to identify risk factors for HDP.</p><p><strong>Results: </strong>Our study included 780,359 pregnant women, and 38,397 women with HDP were identified, with a prevalence of 4.92% (95% CI 4.87-4.97). The prevalence of preeclampsia-eclampsia, gestational hypertension, chronic hypertension, and chronic hypertension with superimposed preeclampsia was 2.28% (95% CI 2.25-2.31), 2.04% (95% CI 2.00-2.07), 0.43% (95% CI 0.41-0.44), and 0.18% (95% CI 0.17-0.19), respectively. From 2012 to 2022, the prevalence of HDP increased from 3.11 to 7.39%, showing an upward trend (<i>χ</i> <sup>2</sup> <sub>trend</sub> = 2220.88, <i>p</i> < 0.01). HDP was associated with the following adverse pregnancy outcomes: maternal deaths (uOR =4.05), maternal near-miss (uOR =6.37), preterm birth (uOR =2.51), stillbirth and neonatal death (uOR =1.45), low birthweight (uOR =4.37), abruptio placentae (uOR =4.45), uterine atony (uOR =1.49), retained placenta (uOR =1.54), puerperal infections (uOR =2.14), abdominal surgical site infections (uOR =2.50), urinary tract infections (uOR =1.60), upper respiratory tract infections (uOR =1.75), heart disease (uOR =2.76), embolism (uOR =2.66), liver disease (uOR =1.25), anemia (uOR =1.38), diabetes mellitus (uOR =2.35), renal disease (uOR =4.66), and pulmonary disease (uOR =4.70, <i>p</i> < 0.05). Results of multivariate logistic regression analysis showed risk factors for HDP: maternal age > 30 years (aOR > 1, <i>p</i> < 0.05), gravidity > = 4 (aOR =1.10, 95% CI 1.05-1.14), primipara (aOR > 1, <i>p</i> < 0.05), and previous cesarean sections (aOR =1.27, 95% CI 1.24-1.31).</p><p><strong>Conclusion: </strong>The prevalence of HDP was relatively high in Hunan Province. HDP was associated with many adverse pregnancy outcomes. Advanced maternal age, high gravidity, primipara, and previous cesarean section were risk factors for HDP.</p>","PeriodicalId":12488,"journal":{"name":"Frontiers in Medicine","volume":"11 ","pages":"1415696"},"PeriodicalIF":3.1000,"publicationDate":"2024-12-20","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11695280/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Frontiers in Medicine","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3389/fmed.2024.1415696","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2024/1/1 0:00:00","PubModel":"eCollection","JCR":"Q1","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Objective: To explore the relationship between hypertensive disorders of pregnancy (HDP) and adverse pregnancy outcomes and explore the risk factors for HDP.

Methods: Data were obtained from the Maternal Near-Miss Surveillance System in Hunan Province, China, 2012-2022. Chi-square trend tests (χ2 trend) were used to determine trends in prevalence by year. Unadjusted odds ratios (uORs) were used to examine the association between HDP and adverse pregnancy outcomes. Multivariate logistic regression analysis (method: Forward, Wald, α = 0.05) and adjusted odds ratios (aORs) were used to identify risk factors for HDP.

Results: Our study included 780,359 pregnant women, and 38,397 women with HDP were identified, with a prevalence of 4.92% (95% CI 4.87-4.97). The prevalence of preeclampsia-eclampsia, gestational hypertension, chronic hypertension, and chronic hypertension with superimposed preeclampsia was 2.28% (95% CI 2.25-2.31), 2.04% (95% CI 2.00-2.07), 0.43% (95% CI 0.41-0.44), and 0.18% (95% CI 0.17-0.19), respectively. From 2012 to 2022, the prevalence of HDP increased from 3.11 to 7.39%, showing an upward trend (χ 2 trend = 2220.88, p < 0.01). HDP was associated with the following adverse pregnancy outcomes: maternal deaths (uOR =4.05), maternal near-miss (uOR =6.37), preterm birth (uOR =2.51), stillbirth and neonatal death (uOR =1.45), low birthweight (uOR =4.37), abruptio placentae (uOR =4.45), uterine atony (uOR =1.49), retained placenta (uOR =1.54), puerperal infections (uOR =2.14), abdominal surgical site infections (uOR =2.50), urinary tract infections (uOR =1.60), upper respiratory tract infections (uOR =1.75), heart disease (uOR =2.76), embolism (uOR =2.66), liver disease (uOR =1.25), anemia (uOR =1.38), diabetes mellitus (uOR =2.35), renal disease (uOR =4.66), and pulmonary disease (uOR =4.70, p < 0.05). Results of multivariate logistic regression analysis showed risk factors for HDP: maternal age > 30 years (aOR > 1, p < 0.05), gravidity > = 4 (aOR =1.10, 95% CI 1.05-1.14), primipara (aOR > 1, p < 0.05), and previous cesarean sections (aOR =1.27, 95% CI 1.24-1.31).

Conclusion: The prevalence of HDP was relatively high in Hunan Province. HDP was associated with many adverse pregnancy outcomes. Advanced maternal age, high gravidity, primipara, and previous cesarean section were risk factors for HDP.

Abstract Image

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
2012-2022年湖南省妊娠期高血压疾病调查
目的:探讨妊娠期高血压疾病(HDP)与妊娠不良结局的关系,并探讨妊娠期高血压疾病的危险因素。方法:数据来自湖南省2012-2022年孕产妇近靶监测系统。采用卡方趋势检验(χ2趋势)确定逐年流行趋势。使用未调整的优势比(uORs)来检查HDP与不良妊娠结局之间的关系。采用多因素logistic回归分析(方法:Forward, Wald, α = 0.05)和校正优势比(aORs)确定HDP的危险因素。结果:我们的研究包括780,359名孕妇,其中38,397名HDP妇女被确定,患病率为4.92% (95% CI 4.87-4.97)。子痫前期-子痫、妊娠期高血压、慢性高血压和慢性高血压合并子痫前期的患病率分别为2.28% (95% CI 2.25-2.31)、2.04% (95% CI 2.00-2.07)、0.43% (95% CI 0.41-0.44)和0.18% (95% CI 0.17-0.19)。从2012年到2022年,黄芪丹参滴丸的患病率从7.39%上升到3.11,显示出上升趋势(χ2趋势 = 2220.88,p   30 年(aOR > 1,p  = 4(优势比= 1.10,95% CI 1.05 - -1.14),初产妇(aOR > 1,p 结论:黄芪丹参滴丸的患病率相对较高的湖南省。HDP与许多不良妊娠结局有关。高龄产妇、高妊娠、初产妇和既往剖宫产是HDP的危险因素。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Frontiers in Medicine
Frontiers in Medicine Medicine-General Medicine
CiteScore
5.10
自引率
5.10%
发文量
3710
审稿时长
12 weeks
期刊介绍: Frontiers in Medicine publishes rigorously peer-reviewed research linking basic research to clinical practice and patient care, as well as translating scientific advances into new therapies and diagnostic tools. Led by an outstanding Editorial Board of international experts, this multidisciplinary open-access journal is at the forefront of disseminating and communicating scientific knowledge and impactful discoveries to researchers, academics, clinicians and the public worldwide. In addition to papers that provide a link between basic research and clinical practice, a particular emphasis is given to studies that are directly relevant to patient care. In this spirit, the journal publishes the latest research results and medical knowledge that facilitate the translation of scientific advances into new therapies or diagnostic tools. The full listing of the Specialty Sections represented by Frontiers in Medicine is as listed below. As well as the established medical disciplines, Frontiers in Medicine is launching new sections that together will facilitate - the use of patient-reported outcomes under real world conditions - the exploitation of big data and the use of novel information and communication tools in the assessment of new medicines - the scientific bases for guidelines and decisions from regulatory authorities - access to medicinal products and medical devices worldwide - addressing the grand health challenges around the world
期刊最新文献
Correction: Oregon primary care providers as a frontline defense in the War on Melanoma™: improving access to melanoma education. Correction: Melanoma toolkit for early detection for primary care clinicians: a 1-year follow-up on outcomes. ED90 of intravenous remimazolam for alleviating preoperative anxiety in children: a prospective dose-finding study. Correlation of vaginal lactic acid bacteria changes with high-risk human papillomavirus-infected cervical intraepithelial neoplasia and nomogram model. Multiplanar MRI approach to the differential diagnosis of central nervous system tumors and tumor-like lesions in patients with HIV: what radiologists need to know.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1